Indivior (NASDAQ:INDV) on Monday said that it will cancel its secondary listing on the London Stock Exchange, effective July ...

The 10-K was filed last week and TechTarget said it will file the 10-Q as soon as practicably possible. If Nasdaq accepts the company's plan to regain compliance, it may grant the company until Oct.

(Reuters) -Pharma firm Indivior said on Monday it will cancel its secondary listing on the London Stock Exchange, effective July 25, maintaining its primary listing on the Nasdaq to reduce costs and ...